Intermittent androgen deprivation in advanced prostate cancer T. M. de Reijke Original Paper Pages: S63 - S66
Second-line treatment of metastatic prostatic carcinoma D. W. W. Newling Original Paper Pages: S73 - S78
Quality of life in patients with prostatic carcinoma: A review and results of a study in N+ disease Prostate-specific antigen as predictor of quality of life G. van AndelK. H. KurthJ. C. J. M. de Haes Original Paper Pages: S79 - S88
Role of proteoglycans in cell adhesion of prostate cancer cells: From review to experiment D. H. J. SchamhartK. -H. Kurth Original Paper Pages: S89 - S96
Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study A. KooistraJ. C. RomijnF. H. Schröder Original Paper Pages: S97 - S105
Conservative non-instrumental treatment of benign prostatic hyperplasia J. L. H. Ruud Bosch Original Paper Pages: S107 - S114